CycloSyn
a NanoCore Health, LLC company
β‑Cyclodextrin Polymer • Exosome‑Hybrid Delivery • RUO

Advanced nanocarriers for multi‑component peptide & small‑molecule delivery.

CycloSyn builds β‑CDP nanocarriers with optional exosome integration to enable modular loading, controlled release, and targeted intracellular delivery—designed for research use only (RUO).

Contact Science View Pipeline
RUO only CRO‑ready packets IP‑first platform

Platform

β‑CDP core with optional lipid stealth layers and exosome‑hybridization for enhanced tropism and uptake. Tunable loading of peptides (BPC‑157, GHK‑Cu, L‑4F, etc.) and small molecules (e.g., FA, resveratrol).

  • Modular loading: peptide + small‑molecule co‑delivery
  • Tunable release & size (50–200 nm typical)
  • Exosome integration for intracellular delivery
  • CRO‑friendly specs & SOPs available

Why CycloSyn

A platform engineered for rapid iteration and CRO execution.

  • RUO‑focused documentation & disclaimers
  • Portfolio approach across multiple indications
  • Clear separation of brand (CycloSyn) and legal entity (NanoCore Health, LLC)

Vendor & CRO

We engage U.S. and international CROs experienced with nanoparticles and EVs.

  • Tech transfer packs (formulations, SOPs, QA checklists)
  • NDA‑friendly engagement process
  • Batch sizes from pilot to 10k+ RUO vials

Pipeline (RUO)

Representative portfolio variants (research‑use only):

Cardio‑ExoBoost Neuro‑ExoRepair Immune‑ExoShield ExoGlow (Cosmetic) Exo‑VitaMood Eterna‑Quantum Vita‑Regen Pro Onco‑Gene Buster Neuro‑Synapse Igniter Immuno‑Shield Max

Detailed composition tables, CRO hand‑off packets, and SOPs available under NDA.

Contact

For CRO inquiries, tech transfer packets, or investor materials, reach out below.

RUO Disclaimer: CycloSyn products are for Research Use Only and are not intended for diagnostic or therapeutic purposes.

Corporate

CycloSyn™ is operated by NanoCore Health, LLC (USA).